Cargando…
Investigating resistin like beta (RETNLB) as a tumor promoter for oral squamous cell carcinoma
BACKGROUND: Oral cavity cancer ranks the sixth most common malignancy worldwide, of which oral squamous cell carcinoma is the predominant type. This study aimed to investigate the function and the underlying mechanism of resistin like beta (RETNLB) in oral squamous cell carcinoma. METHODS: The data...
Autores principales: | Jin, Hong, Miao, Hui, Nie, Yuan-Wen, Lin, Yang-Yang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8218422/ https://www.ncbi.nlm.nih.gov/pubmed/34158059 http://dx.doi.org/10.1186/s13005-021-00272-4 |
Ejemplares similares
-
Association of Resistin Gene Polymorphisms with Oral Squamous Cell Carcinoma Progression and Development
por: Yang, Wei-Hung, et al.
Publicado: (2018) -
Resistin-Like Molecule-β Promotes Invasion and Migration of Gastric Carcinoma Cells
por: Jiang, Rui, et al.
Publicado: (2016) -
Chronic features of allergic asthma are enhanced in the absence of resistin-like molecule-beta
por: LeMessurier, Kim S., et al.
Publicado: (2018) -
Streptococcus mutans promotes tumor progression in oral squamous cell carcinoma
por: Tsai, Ming-Shao, et al.
Publicado: (2022) -
Deletion of resistin-like molecule-beta attenuates angiotensin II-induced abdominal aortic aneurysm
por: Meng, Xiao, et al.
Publicado: (2017)